Tetracycline impregnated fiber11 is a controlled release local delivery device which has recently become commercially available. This device allows controlled release of tetracycline into the periodontal pocket to prolong drug activity. The ment, whereas combined therapy resulted in 0.6 mm gain of attachment ( After 5 years, both groups continued to demonstrate increased probing depth reduction (see Table 2 ). The On the basis of the present clinical findings, further long-term study should be conducted to determine whether tetracycline fiber therapy is beneficial to actual tooth survival and which patients are most likely to benefit from this therapy. The lack of any significant results in the present study makes one question the usefulness of tetracycline fiber therapy in long-term therapy of periodontal diseases.
